Chronic migraine MedDRA version: 17.0 Level: LLT Classification code 10066636 Term: Chronic migraine System Organ Class: 100000004852
Conditions
Interventions
Sponsors
Department of Neuroscience, NTNU
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Informed and written consent Person from 18 to 65 years old Refractory chronic migraine Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 8 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 2
Exclusion criteria
Exclusion criteria: Medication overuse headache Co-morbidity that significantly increases the risk of the procedure Pregnancy Inadequate use of prevention or lactancy Allergies to local anesthetics or IMP
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To evaluate the safety;Secondary Objective: To evaluate the effect of the treatment;Primary end point(s): Adverse events;Timepoint(s) of evaluation of this end point: For the follow-up period of 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): Headache days with moderate or severe headache Migraine attacks ;Timepoint(s) of evaluation of this end point: Average from baseline compared to week 4, 8, and 12. | — |
Countries
Norway
Contacts
Public ContactLars Jacob Stovner
Department of Neuroscience, NTNU
Outcome results
None listed